Difficulty: Medium
Average Score: 90%
Practice
Which of the following outcomes BEST describes the primary toxic effect of bupivacaine on the cardiovascular system?
Correct answer
C
Rationale
In the context of basic patient care, understanding the effects of medications on the cardiovascular system is crucial for patient safety. The correct answer, option C, "Delay of ventricular repolarization," is the primary toxic effect of bupivacaine on the cardiovascular system. Bupivacaine is a local anesthetic that primarily acts by blocking sodium channels in excitable tissues, including cardiac myocytes. This blockade leads to a delay in ventricular repolarization, prolonging the QT interval on an electrocardiogram. This delay can predispose the patient to ventricular arrhythmias, including torsades de pointes.
Option A, "Blockade of norepinephrine release," is incorrect because bupivacaine's mechanism of action does not involve the direct blockade of norepinephrine release. Option B, "Coronary vasoconstriction," is also incorrect as bupivacaine's primary effect is on cardiac conduction rather than coronary vasculature. Option D, "Decreased myocardial contractility," is not the primary toxic effect of bupivacaine on the cardiovascular system; although severe toxicity can ultimately lead to decreased contractility, the primary concern with bupivacaine toxicity is its effect on cardiac conduction.
Educationally, this question highlights the importance of understanding the mechanisms of action of medications to anticipate their potential adverse effects. It underscores the need for healthcare providers to be vigilant in monitoring patients receiving local anesthetics like bupivacaine, especially in procedures where systemic absorption and toxicity are a concern. This knowledge is essential for providing safe and effective patient care in various clinical settings.
Option A, "Blockade of norepinephrine release," is incorrect because bupivacaine's mechanism of action does not involve the direct blockade of norepinephrine release. Option B, "Coronary vasoconstriction," is also incorrect as bupivacaine's primary effect is on cardiac conduction rather than coronary vasculature. Option D, "Decreased myocardial contractility," is not the primary toxic effect of bupivacaine on the cardiovascular system; although severe toxicity can ultimately lead to decreased contractility, the primary concern with bupivacaine toxicity is its effect on cardiac conduction.
Educationally, this question highlights the importance of understanding the mechanisms of action of medications to anticipate their potential adverse effects. It underscores the need for healthcare providers to be vigilant in monitoring patients receiving local anesthetics like bupivacaine, especially in procedures where systemic absorption and toxicity are a concern. This knowledge is essential for providing safe and effective patient care in various clinical settings.